Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Clinical Nutrition (Edinburgh, Scotland)|July 20, 2002
Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjectsSonja D Zuijdgeest-van Leeuwen, Michiel S van der Heijden, Trinet Rietveld, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the NetherlandsTom J N Hermans, Elisabeth E Fransen van de Putte, Simon Horenblas, et al.
Cancer Research|January 22, 2009
Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influenceJonathan R Brody, Tomas Hucl, Christina L Costantino, et al.
Scientific Reports|July 4, 2020
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancerK E van der Vos, D J Vis, E Nevedomskaya, et al.
BJU International|September 24, 2013
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy aloneLaura S Mertens, Richard P Meijer, Wim Meinhardt, et al.
Cancer Research|February 12, 2004
Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic lossChristine A Iacobuzio-Donahue, Michiel S van der Heijden, Mark R Baumgartner, et al.
Cancer Medicine|June 20, 2024
Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitorsLishi Lin, Aletta P I Houwink, Jolanda M van Dieren, et al.
Urologic Oncology|June 19, 2016
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancerEdmund C P Chedgy, James Douglas, Jonathan L Wright, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 9, 2016
Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder CancerKim E M van Kessel, Lorraine M de Haan, Elisabeth E Fransen van de Putte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumorMichiel S van der Heijden, Jonathan R Brody, David A Dezentje, et al.
Pageof 15